Cabvon™

Therapeutic Segment:
PCAB

Generic Name:
Vonoprazan Fumarate

Description:
Vonoprazan is a potassium competitive acid blocker (PCAB) and inhibits H+, K+-ATPase in a reversible and potassium-competitive manner used for the treatment of gastric ulcer, duodenal ulcer, or reflux esopha-gitis.

Indication:

• Treatment of gastric ulcer (GU).
• Treatment of duodenal ulcer (DU).
• Treatment of reflux esophagitis (RE) (erosive esophagitis EE).
• Maintenance treatment of reflux esophagitis (erosive esophagitis) in patients with repeat recurrence and relapse of the condition.
• Prevention of recurrence of gastric ulcer or duodenal ulcer during NSAIDs administration.
• Adjunct to Helicobacter pylori eradication associated with: Gastric ulcer, duodenal ulcer, gastric MALT lymphoma, idiopathic thrombocytopenic purpura, the stomach after endoscopic resection of early stage cancer, or Helicobacter pylori gastritis.

Formulation:

• Tablets

Strength:

• 10mg
• 20mg

Pack Size:

• 30’s